Company: SNWV
Filing Date: 2025-08-21
Form Type: 8-K
Source: 0001628280-25-040975
Chunk: 0

Company: SANUWAVE Health, Inc.
Filing Date: 2025-08-21
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01 Other Events.

As previously disclosed, on March 6, 2024, Sanuwave, Inc. entered into an exclusive license and option agreement with a third-party licensee (the “ Licensee”) in connection with a portfolio of Sanuwave, Inc. patents related to the field of intravascular shockwave applications (the “ Patents”). In exchange for a one-time payment of $2.5 million, Sanuwave, Inc. granted the Licensee an exclusive license to the Patents and an option to acquire the Patents, which option the Licensee exercised on August 21, 2025. In connection with such exercise, the Licensee made a $5.0 million cash payment to Sanuwave, Inc.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                              SANUWAVE HEALTH, INC.                               
  Dated: August 21, 2025      By:                        /s/ Morgan C. Frank      
                              Name:                      Morgan C. Frank          
                              Title:                     Chief Executive Officer